New ultrasound dye could help spot Kids' liver tumors earlier

NCT ID NCT06639828

Recruiting now Diagnosis Sponsor: GE Healthcare Source: ClinicalTrials.gov ↗

First seen Mar 19, 2026 · Last updated May 01, 2026 · Updated 5 times

Summary

This study is testing whether a special ultrasound contrast agent called Sonazoid can help doctors better tell apart benign (non-cancerous) and malignant (cancerous) liver masses in children. About 50 children under 18 with a liver mass will receive an injection of Sonazoid during an ultrasound. The goal is to see if this method is as accurate as CT or MRI scans, but without radiation or sedation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCAL LIVER LESIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Giannina Gaslini Institute
NOT_YET_RECRUITING

Genoa, 16147, Italy
Imperial College Healthcare NHS Trust
RECRUITING

London, W2 1NY, United Kingdom
King's College Hospital NHS Foundation Trust
RECRUITING

London, SE5 9RS, United Kingdom
Munich University Hospital
NOT_YET_RECRUITING

München, 81377, Germany
Papa Giovanni XXIII Hospital
NOT_YET_RECRUITING

Bergamo, 24127, Italy
University Hospitals Bristol and Weston NHS Foundation Trust
RECRUITING

Bristol, BS2 8BJ, United Kingdom

Conditions

Explore the condition pages connected to this study.

FOCAL LIVER LESIONS